Gilead And Novartis Unveil EU Marketing Plans For CAR-T Therapies, But Hurdles Remain

 
• By John Davis
  
Hurdles
Pricing and reimbursement has to be agreed country-by-country in Europe • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from New Products

More from Scrip